We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

136 hedge funds and large institutions have $338M invested in Sanofi Contingent Value Rights in 2013 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 35 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% more capital invested

Capital invested by funds: $324M → $338M (+$13.8M)

7% less funds holding

Funds holding: 146 → 136 (-10)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

40% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 35

59% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 17

Holders
136
Holders Change
-10
Holders Change %
-6.85%
% of All Funds
4.41%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.13%
New
7
Increased
21
Reduced
35
Closed
17
Calls
$1.01M
Puts
–
Net Calls
+$1.01M
Net Calls Change
+$1.01M

Top Buyers

Rank Fund Capital Flow
1
FTCM
Fir Tree Capital Management
New York
+$6.72M
2
MCM
Mason Capital Management
New York
+$5.99M
3
WA
Whitebox Advisors
Minnesota
+$2.25M
4
DI
Dalton Investments
Nevada
+$1.24M
5
SC
Sophrosyne Capital
New York
+$1.09M

Top Sellers

Rank Fund Capital Flow
1
TCA
Taconic Capital Advisors
New York
-$5.79M
2
RCM
Royal Capital Management
New York
-$3.55M
3
FCM
Farallon Capital Management
California
-$2.51M
4
BlackRock
BlackRock
New York
-$2.27M
5
PCM
Pentwater Capital Management
Florida
-$1.69M
Name Holding Trade Value Shares
Change 		Change in
Stake
PNC Financial Services Group
76
PNC Financial Services Group
Pennsylvania
$34K -$1.59K -835 -5%
PPA
77
Parametric Portfolio Associates
Washington
$32K -$3.34K -1,755 -10%
HK
78
Horizon Kinetics
New York
$32K +$766 +402 +3%
Commonwealth Equity Services
79
Commonwealth Equity Services
Massachusetts
$30K +$825 +433 +3%
Truist Financial
80
Truist Financial
North Carolina
$30K +$1.36K +712 +5%
LPL Financial
81
LPL Financial
California
$26K -$394 -207 -2%
CGT
82
Capital Guardian Trust
California
$24K – – –
BlackRock
83
BlackRock
New York
$23K -$2.27M -1,190,085 -99%
PHIMC
84
Private Harbour Investment Management & Counsel
Ohio
$23K -$381 -200 -2%
DA
85
Dillon & Associates
Michigan
$21K – – –
UOC
86
University of Chicago
Illinois
$21K – – –
Bank of New York Mellon
87
Bank of New York Mellon
New York
$21K +$20K +10,522 New
TCM
88
Touradji Capital Management
Florida
$20K – – –
Creative Planning
89
Creative Planning
Kansas
$19K – – –
Deutsche Bank
90
Deutsche Bank
Germany
$17K – – –
Invesco
91
Invesco
Georgia
$16K – – –
US Bancorp
92
US Bancorp
Minnesota
$15K +$1.91K +1,000 +16%
CTC
93
Central Trust Company
Missouri
$14K – – –
BPBT
94
Boston Private Bank & Trust
Massachusetts
$9K – – –
TWA
95
TCI Wealth Advisors
Arizona
$9K – – –
WTC
96
WhitTier Trust Company
Nevada
$6K -$571 -300 -9%
Citigroup
97
Citigroup
New York
$6K – – –
M&T Bank
98
M&T Bank
New York
$6K – – –
LTFS
99
Ladenburg Thalmann Financial Services
Florida
$5K – – –
RNS
100
Robert N. Shapiro
$5K – – –
2 3
4
5 6

GCVRZ Hedge Fund Activity: Q3 2013 in Review

136 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q3 2013, worth a combined $338M — up 4.3% from $324M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of GCVRZ and 7 opened new positions — a net loss of 10 holders — while 35 trimmed existing stakes and 21 added.

The largest buyer was Fir Tree Capital Management, adding an estimated $6.72M. The largest seller was Taconic Capital Advisors, exiting entirely with an estimated $5.79M sold.

  • 136 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q3 2013, down from 146 in Q2 2013.
  • Funds reported $338M of Sanofi Contingent Value Rights stock for Q3 2013, up 4.3% quarter-over-quarter.
  • 7 funds opened new Sanofi Contingent Value Rights positions in Q3 2013 and 17 closed out, a net change of -10 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q3 2013 was Fir Tree Capital Management, an estimated $6.72M added.
  • The largest Sanofi Contingent Value Rights seller in Q3 2013 was Taconic Capital Advisors, an estimated $5.79M sold.

Based on aggregated 13F filings for Q3 2013.